These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7195844)

  • 1. The suppression of tumorigenicity in human X mouse cell hybrids. II. The relationship between tumorigenicity and parameters of transformation in vitro.
    Chopan M; Kopelovich L
    Exp Cell Biol; 1981; 49(3):132-40. PubMed ID: 7195844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suppression of tumorigenicity in human X mouse cell hybrids. I. Derivation of hybrid clones, chromosome analysis and tumorigenicity studies.
    Chopan M; Kopelovich L
    Exp Cell Biol; 1981; 49(2):78-89. PubMed ID: 7202797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between characteristics of transformation and malignancy of intra and interspecific somatic hybrid cells.
    Foa C; Simonetti J; Berebbi M; Fischer P; Vetterlein M
    Oncology; 1978; 35(2):58-62. PubMed ID: 652265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transformation markers and suppression of tumorigenicity in human cell hybrids.
    Larizza L; Tenchini ML; Mottura A; De Carli L; Colombi M; Barlati S
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):845-51. PubMed ID: 6961038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transmission and expression of malignancy in somatic hybrid cell lines (hamster/hamster, mouse/mouse, hamster/mouse)].
    Berebbi M
    Bull Cancer; 1976; 63(2):145-73. PubMed ID: 186142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control.
    Stanbridge EJ; Wilkinson J
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1466-9. PubMed ID: 274733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of myogenesis by somatic cell hybridization. II. Retention of myogenic competence and suppression of transformed properties in hybrids between differentiation competent and incompetent rat L6 myoblasts.
    Lawrence JB; Coleman JR
    J Cell Physiol; 1983 Jan; 114(1):99-110. PubMed ID: 6826666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for suppression of cellular growth in vitro and selection against the indigenous mouse X chromosome in A9 cell hybrids after microcell-mediated transfer of an X from other mammalian species.
    Islam MQ; Islam K
    Cytogenet Cell Genet; 2000; 88(1-2):110-3. PubMed ID: 10773682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on transformation markers and tumorigenicity in segregant clones from a human hybrid line.
    Tenchini ML; Larrizza L; Mottura A; Colombi M; Barlati S; De Carli L
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1143-9. PubMed ID: 6684560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of in vivo malignancy with in vitro properties of human-mouse hybrid cells.
    Bordelon MR; Shows TB; Chen TR; Stubblefield E
    J Natl Cancer Inst; 1976 Mar; 56(3):499-508. PubMed ID: 1255782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus.
    Becker D; Kurth R; Critchley D; Friis R; Bauer H
    J Virol; 1977 Mar; 21(3):1042-55. PubMed ID: 191634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the transformed phenotype and tumorigenicity in somatic cell hybrids.
    Marshall CJ
    J Cell Sci; 1979 Oct; 39():319-27. PubMed ID: 575140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of transformation and tumorigenicity in interspecies hybrids of human SV40-transformed and mouse 3T3 cell lines.
    Howell N
    Cytogenet Cell Genet; 1982; 34(3):215-29. PubMed ID: 6291863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
    Kaelbling M; Klinger HP
    Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of the traits characterizing the cell surface in hybrids of malignant and nonmalignant cells].
    Fridlianskaia II; Polianskaia GG; Blomquist G; Tatulian SA; Pinaev GP
    Tsitologiia; 1983 May; 25(5):593-600. PubMed ID: 6879728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity of mouse-human diploid hybrids in nude mice.
    Croce CM; Aden C; Koprowski H
    Science; 1975 Dec; 190(4220):1200-2. PubMed ID: 173020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfilament bundles in transformed mouse CLID x transformed CHO cell hybrids. Correlation with tumorigenicity in nude mice.
    Celis JE; Small JV; Kaltoft K; Celis A
    Exp Cell Res; 1979 Apr; 120(1):79-86. PubMed ID: 571343
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of correlation between growth characteristics, agglutinability by plant lectins and the malignant phenotype.
    Berman LD
    Int J Cancer; 1975 Jun; 15(6):973-9. PubMed ID: 1150351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes.
    Klinger HP
    Cytogenet Cell Genet; 1980; 27(4):254-66. PubMed ID: 6934067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.